Hydrocortisone buteprate, also known as hydrocortisone probutate and as hydrocortisone butyrate propionate, is a topical corticosteroid.[2][3] It is an ester of hydrocortisone (cortisol) with butyric acid and propionic acid.
Clinical data | |
---|---|
Trade names | Pandel |
Other names | Hydrocortisone probutate; Hydrocortisone 17α-butyrate 21-propionate; Hydrocortisone butyrate propionate, hydrocortisone probutate (USAN US) |
AHFS/Drugs.com | Monograph |
Pregnancy category |
|
Routes of administration | Topical |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.069.730 |
Chemical and physical data | |
Formula | C28H40O7 |
Molar mass | 488.621 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
References
edit- ^ a b "Hydrocortisone topical Use During Pregnancy". Drugs.com. 5 December 2019. Retrieved 13 September 2020.
- ^ Drugs.com: Hydrocortisone Buteprate topical
- ^ Sears HW, Bailer JW, Yeadon A (1997). "Efficacy and safety of hydrocortisone buteprate 0.1% cream in patients with atopic dermatitis". Clinical Therapeutics. 19 (4): 710–9. doi:10.1016/s0149-2918(97)80095-1. PMID 9377615.
External links
edit- "Hydrocortisone probutate". Drug Information Portal. U.S. National Library of Medicine.